Form 4: iRhythm CFO Daniel Wilson Acquires 8,361 RSUs

iRhythm Holdings, Inc. Chief Financial Officer Daniel G. Wilson acquired 8,361 Restricted Stock Units, vesting over four years.

Summary

• Daniel G. Wilson, Chief Financial Officer of iRhythm Holdings, Inc. (IRTC), acquired 8,361 shares of Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction occurred on February 25, 2026, with a deemed execution date of February 25, 2026.
• Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
• The RSUs will vest 25% on March 1, 2027, and 25% on each one-year anniversary thereafter, contingent on Mr. Wilson's continued service.
• Following this transaction, Mr. Wilson directly beneficially owns 39,055 shares of Common Stock.
• An additional 100 shares are indirectly beneficially owned through The Wilson Living Trust dated July 9, 2015, where Mr. Wilson serves as Trustee.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive, routine event. While not indicative of extraordinary performance, it signifies continued executive alignment with shareholder interests through equity compensation.

Positives

• The acquisition of Restricted Stock Units by the Chief Financial Officer aligns management's long-term interests with those of shareholders, as the value of the RSUs is tied to the company's stock performance.
• The multi-year vesting schedule encourages executive retention and sustained focus on long-term company growth and performance.

Risks

• The vesting of the Restricted Stock Units is contingent upon Daniel G. Wilson continuing as a service provider through each vesting date, meaning the shares could be forfeited if his employment ceases before full vesting.

Future Outlook

The future outlook indicates a commitment to retaining key executive talent through equity incentives, with the vesting schedule extending through at least March 2030, subject to continued service.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units to a Chief Financial Officer is a standard practice in executive compensation across the healthcare technology sector. This mechanism is widely used to incentivize long-term performance and align executive interests with shareholder value creation, reflecting common corporate governance trends.

Comparison to Industry Standards

• RSU grants with multi-year vesting schedules are a standard component of executive compensation packages across various industries, including healthcare technology.
• This practice aligns executive incentives with long-term shareholder value, similar to compensation structures observed at peer companies like Dexcom (DXCM) or Insulet (PODD), which also utilize performance-based equity awards.
• The $0 price for RSUs is typical, as they represent a contingent right to receive shares upon vesting, rather than a purchase.

Stakeholder Impact

• Shareholders: The RSU grant aligns the Chief Financial Officer's financial interests with long-term shareholder value, potentially fostering more prudent financial management and strategic decisions.
• Employees: This transaction is specific to executive compensation and does not directly impact the broader employee base, though it reflects the company's approach to executive incentives.

Next Steps

• The first tranche of 25% of the RSUs will vest on March 1, 2027, followed by subsequent 25% tranches on each one-year anniversary thereafter, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event (RSU grant) and does not provide sufficient new information to warrant a change in investment recommendation. While it indicates continued executive alignment, it is not a catalyst for significant price movement or a re-evaluation of the company's fundamentals. Investors should consider this as part of ongoing executive incentive structures.

Keywords

iRhythm Holdings, IRTC, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Daniel G. Wilson, CFO, Equity Grant, Vesting